NMN exercise research contains promising endurance signals, but it does not establish a general boost in fitness, strength or everyday energy. Read the exact outcome: a laboratory threshold, a running test and a fatigue questionnaire answer different questions. The study's participants and training conditions also matter.
When a supplement story says “more energy,” it is natural to imagine an easier run, a stronger workout and less afternoon tiredness together. Those are different goals. A useful evidence review keeps them separate rather than letting one positive finding stand in for all three.
Our NMN results timeline guide explains measurement windows and why a blood marker is not a feeling. This article goes deeper into exercise endpoints, compares findings from different populations and adds a practical map for translating a performance claim into a testable question.
What did the often-cited runners trial actually measure?
The 2021 trial found changes in selected ventilatory-threshold measures, without a significant advantage in VO₂max or peak power. Forty-eight recreational runners, including eight women, were randomized to NMN or placebo for six weeks while all groups followed regular exercise training. Testing used a cycle ergometer, rather than a running race. Liao et al., randomized trial.
A ventilatory threshold describes a transition in the breathing response as exercise intensity rises. VO₂max describes maximal oxygen uptake. A result at a threshold does not mean that maximal capacity also increased. The study was small, included few women and tested NMN alongside training; it cannot establish a women-specific response or an effect without exercise. Its protocol is not a retail-product serving recommendation. Trial methods and limitations.
Notice the wording you carry away: “a particular measure changed under these conditions” is more precise than “this makes runners faster.” Keep the laboratory finding intact rather than converting it into a personal race prediction.
What do newer exercise studies add?
A newer result can sharpen the question without settling it for every reader. A study published in the 2026 journal issue tested NMN, paprika xanthophyll, their combination and placebo in male collegiate track-and-field athletes. NMN did not improve endurance performance at the eight-week primary endpoint. The authors described possible combination signals at four weeks and in stratified analyses; those do not establish NMN-alone effectiveness. Nishimura et al., randomized trial.
This is a useful example of why the main result, earlier time points and subgroup findings should stay visibly separate. A promising finding in a combination group does not tell you which ingredient produced it. It also does not validate a different retail blend.
A September 2026 network meta-analysis reported stronger signals for NMN in endurance-related outcomes than in neuromuscular strength, while perceived-fatigue results were not robust. It combined different NAD-related compounds, populations and tests. Many comparisons between compounds relied on indirect evidence, and trials were generally short. Read it as a research signal that needs context, rather than a universal performance ranking or a dosing plan. 2026 domain-specific review.
Does endurance evidence also mean stronger muscles?
No: strength needs its own measured result. A 2025 systematic review of NMN and NR trials in older adults examined muscle mass and function. Its NMN analyses found no significant improvements in skeletal muscle index, handgrip strength, gait speed or the five-time chair-stand test. Included study populations had mean ages from 60.9 to 83 years. These findings do not directly answer what happens in a younger recreational runner. Prokopidis et al., systematic review and meta-analysis.
The studies can differ without one being meaningless. They recruit different people and ask different questions. For your own goal, look for the closest outcome and population; do not average unlike claims into a vague promise of “better performance.”
A claim-to-question map for NMN exercise research
Translate the promise into the result you actually want before judging the evidence. This original editorial map is a reading tool, not a testing protocol or a recommendation to take a supplement.
| The claim you hear | The reader question | What to ask the source |
|---|---|---|
| “Better endurance” | For a lab test, an ordinary walk or my race? | Name the exact test and comparison |
| “More workout energy” | Measured performance, or how someone felt? | Separate objective results from personal reports |
| “Stronger muscles” | Which strength task improved? | Show a strength outcome, not a cardio result |
| “Works for women” | Were women studied in enough detail? | Give the participant mix and any sex-specific analysis |
| “This formula is proven” | Was this finished product tested? | Identify the actual study formulation |
For example, if your goal is to finish an ordinary workout feeling less exhausted, a headline about a laboratory exercise measure has not yet answered your question. Ask whether the source measured that experience, in comparable people, against a suitable control. A missing answer should remain missing; confidence in the headline cannot supply it.
How to approach a product decision after reading the evidence
Evidence interpretation and product suitability are separate decisions. Once you have named your goal, review the current NMN Daily product information and complete label. Check the actual ingredients and directions, and discuss personal suitability with a qualified professional when needed. This article supplies no exercise-specific serving or stacking plan.
Bring the claim you are evaluating, not just the product name: “I want to understand whether this evidence addresses my endurance goal” is a more useful starting point than “will this give me energy?” Leave room for an answer that the available research does not establish the outcome you want.
Unexplained fatigue deserves a different next step. NHS advises seeking medical advice if tiredness has lasted a few weeks without a clear explanation, affects daily life or comes with other symptoms. Do not use a performance article to diagnose a supplement need or postpone care. NHS tiredness and fatigue guidance.
Keep the conclusion as specific as the evidence
There are reasons to keep studying NMN and endurance, alongside unresolved questions about who benefits and which outcomes change. A useful decision preserves that uncertainty. Match the evidence to your goal, distinguish the main endpoint from exploratory results, and keep ingredient research separate from a finished-product claim.
Considering NMN Daily?
Review the current NMN Daily product details and complete label as a separate suitability decision after reading the exercise evidence.
The studies discussed did not test Yesnap NMN Daily. No personal dosing or finished-product performance result is promised.
Frequently asked questions
Does NMN improve VO₂max?
The often-cited runners trial did not find a significant VO₂max advantage. Its positive threshold findings should not be relabeled as a VO₂max result. Runners trial.
Does NMN endurance research prove more daily energy?
No. An exercise endpoint and a fatigue report are different outcomes. The 2026 review found that endurance signals did not translate into robust perceived-fatigue benefits. Domain-specific review.
Can women use the runners study to predict their own result?
It included only eight women and does not establish a women-specific effect. Treat it as a limited research signal rather than a personal forecast. Trial participants.
Should I copy the study's NMN amount for workouts?
No. Research protocols are not directions for a retail formula. Use the current product label and qualified advice for personal decisions; this guide provides no workout dosing instructions.
Sources and editorial note
- Liao et al. (2021): randomized recreational-runners trial
- Nishimura et al. (2026 issue; first online 2025): randomized athlete trial
- 2026 systematic review and network meta-analysis: fatigue and functional outcomes
- Prokopidis et al. (2025): muscle mass and function review
- NHS: tiredness and fatigue
Prepared by Yesnap; suggested update date October 2, 2026. Educational information, not individual treatment advice. Research amounts, mechanisms and anecdotes are not promises about a finished product.